blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3414261

EP3414261 - A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.2022
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  03.12.2021
FormerGrant of patent is intended
Status updated on  15.08.2021
FormerExamination is in progress
Status updated on  12.11.2019
FormerRequest for examination was made
Status updated on  16.11.2018
FormerThe international publication has been made
Status updated on  18.08.2017
Formerunknown
Status updated on  20.02.2017
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Bracco Suisse SA
Via Ponteggia 23
6814 Cadempino / CH
[2022/01]
Former [2019/10]For all designated states
Bracco Suisse SA
Via Ponteggia 23
6814 Cadempino / CH
Former [2018/51]For all designated states
Bracco Suisse SA
Galleria 2
Via Cantonale
6928 Manno / CH
Inventor(s)01 / BETTINGER, Thierry
Route de la Galaise 31
1228 Plan-les-Ouates / CH
02 / CHERKAOUI, Samir
Route de la Galaise 31
1228 Plan-les-Ouates / CH
03 / KOLLER, Christian
Route de la Galaise 31
1228 Plan-les-Ouates / CH
04 / LOBITO, Adrian
530 Harbor Boulevard
Belmont California 94002 / US
05 / CRIVELLIN, Federico
Bracco Imaging S.p.A. - CRB Via Ribes n°5
10010 Colleretto Giacosa (TO) / IT
06 / BUSSAT, Philippe
Bracco Suisse SA Route de la Galaise 31
1228 Plan-les-Ouates / CH
07 / MAISANO, Federico
Bracco Imaging S.p.A. - CRB Via Ribes n°5
10010 Colleretto Giacosa (TO) / IT
 [2018/51]
Representative(s)Freyria Fava, Cristina
Buzzi, Notaro & Antonielli d'Oulx S.p.A.
Corso Vittorio Emanuele ll, 6
10123 Torino / IT
[2022/01]
Former [2018/51]Ravizza, Claudio
Bracco Suisse S.A.
Intellectual Property Department
31, route de la Galaise
1228 Plan-les-Ouates / CH
Application number, filing date17704241.309.02.2017
[2018/51]
WO2017EP52821
Priority number, dateWO2016EP15486809.02.2016         Original published format: PCT/EP2016/154868
[2018/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017137477
Date:17.08.2017
Language:EN
[2017/33]
Type: A1 Application with search report 
No.:EP3414261
Date:19.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 17.08.2017 takes the place of the publication of the European patent application.
[2018/51]
Type: B1 Patent specification 
No.:EP3414261
Date:05.01.2022
Language:EN
[2022/01]
Search report(s)International search report - published on:EP17.08.2017
ClassificationIPC:C07K14/705, A61K38/00, A61K49/00, A61K49/22
[2021/36]
CPC:
C07K14/705 (EP); A61K49/0032 (EP); A61K49/0056 (EP);
A61K49/0084 (EP); A61K49/221 (EP); A61K49/223 (EP);
A61K38/00 (EP); G01N2333/70564 (EP) (-)
Former IPC [2021/32]A61K38/00, A61K49/00, A61K49/22
Former IPC [2018/51]C07K14/705, A61K38/17
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/51]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:REKOMBINANTES CHIMÄRES PROTEIN FÜR SELECTIN-TARGETING[2018/51]
English:A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING[2018/51]
French:PROTÉINE CHIMÉRIQUE RECOMBINANTE CIBLANT DES SÉLECTINES[2021/32]
Former [2018/51]PROTÉINE CHIMÉRIQUE RECOMBINANTE POUR LE CIBLAGE DE SÉLECTINES
Entry into regional phase03.09.2018National basic fee paid 
03.09.2018Designation fee(s) paid 
03.09.2018Examination fee paid 
Examination procedure03.09.2018Examination requested  [2018/51]
03.09.2018Date on which the examining division has become responsible
18.03.2019Amendment by applicant (claims and/or description)
13.05.2019Despatch of communication of loss of particular rights: Claims {1}
15.11.2019Despatch of a communication from the examining division (Time limit: M06)
07.05.2020Reply to a communication from the examining division
03.11.2020Despatch of a communication from the examining division (Time limit: M04)
20.01.2021Reply to a communication from the examining division
16.08.2021Communication of intention to grant the patent
30.11.2021Fee for grant paid
30.11.2021Fee for publishing/printing paid
30.11.2021Receipt of the translation of the claim(s)
Opposition(s)06.10.2022No opposition filed within time limit [2022/50]
Request for further processing for:Loss of rights: Claims
30.05.2019Request for further processing filed
30.05.2019Full payment received (date of receipt of payment)
Fees paidRenewal fee
03.09.2018Renewal fee patent year 03
27.02.2020Renewal fee patent year 04
25.02.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
MT05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
[2024/44]
Former [2024/22]AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
MK05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2024/20]AL05.01.2022
AT05.01.2022
CY05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2023/01]AL05.01.2022
AT05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/49]AT05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SK05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/48]AT05.01.2022
CZ05.01.2022
EE05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/47]AT05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
MC05.01.2022
PL05.01.2022
RO05.01.2022
RS05.01.2022
SM05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/42]AT05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
IS05.05.2022
PT05.05.2022
Former [2022/39]AT05.01.2022
FI05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
PT05.05.2022
Former [2022/36]AT05.01.2022
HR05.01.2022
LT05.01.2022
LV05.01.2022
PL05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
PT05.05.2022
Former [2022/35]HR05.01.2022
LT05.01.2022
RS05.01.2022
BG05.04.2022
NO05.04.2022
PT05.05.2022
Former [2022/34]LT05.01.2022
NO05.04.2022
PT05.05.2022
Former [2022/33]LT05.01.2022
NO05.04.2022
Cited inInternational search[I]WO2008131217  (OREGON HEALTY & SCIENCE UNIVER [US], et al) [I] 1-36 * page 15, line 11 - page 16, line 25 * * claims 12-16 *;
 [ID]WO2012020030  (BRACCO SUISSE SA [CH], et al) [ID] 1-36 * page 18, line 29 - page 19, line 5 * * claim 7; sequence 3 *;
 [A]  - SAORI UMEKI ET AL, "Anti-adhesive property of P-selectin glycoprotein ligand-1 (PSGL-1) due to steric hindrance effect", JOURNAL OF CELLULAR BIOCHEMISTRY, US, (20130616), vol. 114, no. 6, doi:10.1002/jcb.24468, ISSN 0730-2312, pages 1271 - 1285, XP055288257 [A] 1-36 * abstract * * page 1281, column l, paragraph 2 - column r, paragraph 1 * * figure 7 * * page 1283, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/jcb.24468
 [A]  - R D Cummings ET AL, "Structure and function of the selectin ligand PSGL- Key words", Braz J Med Biol Res Brazilian Journal of Medical and Biological Research, (19990101), URL: http://www.scielo.br/pdf/bjmbr/v32n5/3499c.pdf, (20160713), XP055288260 [A] 1-36 * page 522, column r, line 1 - page 523, column l, paragraph 1 * * page 524, column l, paragraph 2 - column r, paragraph 1 *
 [A]  - LIU W ET AL, "Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19980320), vol. 273, no. 12, doi:10.1074/JBC.273.12.7078, ISSN 0021-9258, pages 7078 - 7087, XP002116309 [A] 1-36 * abstract * * page 7079, column l, paragraph 2 * * figure 1 *

DOI:   http://dx.doi.org/10.1074/jbc.273.12.7078
by applicantUS4276885
 EP0324938
 US5021556
 US5075099
 US5118797
 US5183653
 EP0554213
 US5271928
 WO9409829
 US5362476
 US5364613
 US5367080
 US5387409
 US5409689
 US5413774
 US5445813
 US5556610
 US5574140
 US5597549
 US5608110
 US5627286
 US5656254
 US5659041
 US5662885
 US5665329
 US5688487
 US5711933
 US5720934
 US5780006
 US5827817
 US5827504
 US5886142
 US5976495
 US6093382
 US6143274
 US6277975
 US6333021
 US6509324
 WO03008390
 WO03008394
 WO2004069284
 WO2005062828
 WO2005105840
 WO2008071679
 WO2012020030
 WO2013135750
 WO2014191467
    - SAKO ET AL., CELL, (1993), vol. 75, no. 6, pages 1179 - 1186
    - LIU ET AL., J. BIOL. CHEM., (1998), vol. 12, pages 7078 - 7087
    - CUMMINGS RD, BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, (1999), vol. 32, pages 519 - 528
    - SAKO ET AL., CELL, (1995), vol. 83, pages 323 - 331
    - FUGANG LI ET AL., J. BIOL. CHEM, (1996), vol. 271, pages 3255 - 3264
    - DE KRUIF, J.; LOGTENBERG T., J. BIOL. CHEM., (1996), vol. 271, pages 7630 - 7634
    - CHINGWEI V. LEE ET AL., J. IMMUNOLOGICAL METHODS, (2004), vol. 284, pages 119 - 132
    - SWAROOP ET AL., PROC. NATL. ACAD. SCI., (1992), vol. 89, pages 266 - 270
    - R.D CUMMING, BRAZ. J. BIOL. RES, (1999), vol. 32, no. 5, pages 520 - 528
    - D. SAKO, CELL, (1995), vol. 83, pages 323 - 331
    - R.D CUMMING, BRAZ. J. BIOL. RES., (1999), vol. 32, no. 5, pages 520 - 528
    - LIU ET AL., J. BIOL. CHEM., (1998), vol. 273, pages 7078 - 7087
    - LATTUADA L. ET AL., CHEM SOC. REV, (2011), vol. 40, pages 3019 - 3049
    - LIU S.; EDWARDS S., BIOCONJUGATE CHEM., (2001), vol. 12, pages 7 - 34
    - PRICE EW; ORVIG, CHEM. SOC. REV., (2014), vol. 43, page 260
    - HERMANN ET AL., DALTON TRANS., (2008), pages 3027 - 3047
    - PRICE EW; ORVIG C, CHEM. SOC. REV, (2014), vol. 43, page 260
    - LIU; EDWARDS, CHEM REV, (1999), vol. 99, pages 2235 - 2268
    - GIBBS S.L., QUANT IMAGING MED SURG, (2012), vol. 2, no. 3, pages 177 - 187
    - "Pharmacokinetics", Goodman & Gilman, pages 3 - 27
    - CHOU T-H. ET AL., CYTOKINE, (2010), vol. 51, pages 107 - 111
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.